US Patent Issued to Novartis on Dec. 16 for "Methods of treating autoimmune diseases using interleukin-17 (IL-17) antagonists" (American, Swiss Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,449, issued on Dec. 16, was assigned to Novartis AG (Basel, Switzerland).

"Methods of treating autoimmune diseases using interleukin-17 (IL-17) antagonists" was invented by Abhijit Bapat (Mountain Lakes, N.J.), Thomas Dumortier (Basel, Switzerland), Meryl Mendelson (Larchmont, N.Y.), Shephard Mpofu (Oberwil, Switzerland) and Luminita Pricop (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for treating patients having autoimmune diseases, e.g., methods for treating psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), e.g., non-radiographic axial spondyloarthritis (nr-axSpA) or ankylosing spon...